Category Archive for: ‘FDA’

New Dietary Advice From Government: Just Eat Less

The New York TimesJanuary 31, 2011By ANDREW MARTIN The latest nutrition guidelines released Monday by the federal government reiterate much of the advice from previous years: eat less salt and saturated fats, eat more fruits and vegetables and whole grains. But there is a startling difference. This time, the government suggests that Americans also just eat less. More specifically, the …

Read More

FDA Plans Curb Of Opioid Pain Killer Abuse

December 5, 2009VisitBulgariaHenry Aaron The U. S. Food and Drug Administration (FDA) has been provided with plans from manufacturers of 24-different prescription painkillers for curbing opioid drug abuse. FDA has been pressurizing these pharmaceutical companies to figure out a way of stopping the hundreds of fatal medication overdoses that occur each year. According to the Associated Press, executives from Johnson …

Read More

FDA Cracks Down on Ibuprofen Pain Relief Gels

August 20, 2009Associated PressMatthew PerroneThe Food and Drug Administration has issued warnings to eight companies for illegally marketing pain relief ointments containing ibuprofren.Regulators said in a statement Thursday the companies do not have federal persmission to market their products, which mix the popular pain relief drug wtih other ingredients. While ibuprofen is available in a variety of tablets like Advil, …

Read More

If 2 Painkillers Are Banned, What Next?

July 2, 2009HealthDay NewsForbes.com Banning the popular painkillers Percocet and Vicodin, which a U.S. health advisory panel has urged, would not be as drastic as it sounds, some medical experts contend. The reason, they say, is that other options are available. A U.S. Food and Drug Administration advisory panel made its recommendation Tuesday. It followed the release in May of …

Read More

Ban Is Advised on 2 Top Pills for Pain Relief

July 1, 2009By GARDINER HARRISNew York Times ADELPHI, Md. — A federal advisory panel voted narrowly on Tuesday to recommend a ban on Percocet and Vicodin, two of the most popular prescription painkillers in the world, because of their effects on the liver. The two drugs combine a narcotic with acetaminophen, the ingredient found in popular over-the-counter products like Tylenol …

Read More

FDA OKs Fibromyalgia Drug Savella

Savella Joins Cymbalta and Lyrica as Drugs Approved for Fibromyalgia PatientsBy Miranda HittiWebMD Health NewsReviewed by Louise Chang, MD Jan. 15, 2009 — The FDA has approved a new drug called Savella for the management of fibromyalgia. Savella belongs to a class of drugs called serotonin and norepinephrine reuptake inhibitors (SNRIs), which include some antidepressants. The drug companies behind Savella …

Read More

Spinal Surgery to Get You on Your Feet Faster

DECEMBER 29, 2008, 10:10 P.M. ET By LAURA JOHANNESThe Wall Street Journal A new minimally invasive spinal surgery trims hospital stays and affords a shorter recovery time than traditional methods, says a company that sells equipment used in the procedure. Physicians say the surgery trims recovery times but say more research is needed on its efficacy. More…PainCareMD

Read More

FDA Approves New Drug to Alleviate Moderate to Severe Pain

FDA NewsNovember 24, 2008 The U.S. Food and Drug Administration has approved Tapentadol hydrochloride, an immediate-release oral tablet for the relief of moderate to severe acute pain. Tapentadol is a centrally-acting synthetic analgesic that is available in doses of 50 mg, 75 mg, or 100 mg. “This approval offers health care professionals an additional choice for treating moderate to severe …

Read More

Lilly Pulls FDA Application For Cymbalta For Pain

Nov 28, 2008 CHICAGO (Reuters) – Eli Lilly and Co (LLY.N: Quote, Profile, Research, Stock Buzz) said on Friday it withdrew an application to market its anti-depressant Cymbalta for the management of chronic pain because U.S. health regulators raised questions about the drug’s effectiveness and dosing. Lilly said it made its decision to pull the supplemental New Drug Application for …

Read More

FDA Accepts REMOXY New Drug Application and Grants Priority Review

Fox Business, Tuesday, August 12, 2008 SAN MATEO, Calif. and BRISTOL, Tenn., Aug 12, 2008 /PRNewswire-FirstCall via COMTEX/ —-Pain Therapeutics, Inc. and King Pharmaceuticals, Inc. today announced that the New Drug Application (NDA) for REMOXY(r) was accepted and granted Priority Review by the U.S. Food and Drug Administration (FDA). The FDA typically grants Priority Review to drug candidates that have …

Read More

Page 1 of 212»